Renalytix Plc (LON:RENX – Get Free Report) fell 4.6% during mid-day trading on Tuesday . The company traded as low as GBX 30 ($0.37) and last traded at GBX 31 ($0.39). 34,497 shares traded hands during trading, a decline of 94% from the average session volume of 618,802 shares. The stock had previously closed at GBX 32.50 ($0.40).
Renalytix Stock Down 3.3 %
The business’s 50 day moving average is GBX 32.84 and its 200 day moving average is GBX 28.03. The company has a quick ratio of 2.42, a current ratio of 0.59 and a debt-to-equity ratio of 173.95. The company has a market cap of £34.78 million, a P/E ratio of -80.56 and a beta of 1.92.
Renalytix Company Profile
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.
Recommended Stories
- Five stocks we like better than Renalytix
- The “How” and “Why” of Investing in 5G Stocks
- Comprehensive PepsiCo Stock Analysis
- 3 Tickers Leading a Meme Stock Revival
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What Are Dividend Champions? How to Invest in the Champions
- Bear Market Funds to Watch This Year
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.
